ArticleNeurology open access2025

A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial.

Ka-Ho Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.